Bracco Diagnostics Inc., the US-based subsidiary of Bracco Imaging SpA, develops and markets clinical agents for use in X-ray/Computed Tomography (CT), Nuclear Medicine and Magnetic Resonance Imaging (MRI) in the U.S. and Canada. Our leading products represent a significant share of the U.S. diagnostic contrast media market. With headquarters and research offices in Princeton, New Jersey, the company is also developing contrast agents for ultrasound procedures.
Committed to Science, Committed to You. Our specialized R&D and technological innovation teams are targeted at developing high-quality processes and products that are safe, effective, and increasingly in tune with the needs of patients and physicians.